MapLight Therapeutics, Inc.

Contributing Author

Recent Articles by MapLight Therapeutics, Inc.

Jan-09	MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026 MPLT GlobeNewswire
Jan-05	MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer's Disease Psychosis MPLT GlobeNewswire
Dec-16	SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies MPLT GlobeNewswire
Dec-04	MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress MPLT +8.39% GlobeNewswire
Oct-29	MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares MPLT GlobeNewswire
Oct-26	MapLight Therapeutics Announces Pricing of Initial Public Offering MPLT GlobeNewswire